Skip to content

02496.HK

Wuhan YZY Biopharma Co Ltd

HKSE · Healthcare · Biotechnology · CN

HKD 3.30
−8.33%
Ask drillr
  • Aug 28, 2026, 09:36 UTC

    Youshiyou Biopharmaceutical reported interim results for the six months ended June 2026, with revenue of 33.143 million RMB, down 10.9% year-on-year, and a narrowed net loss of 6.26 million RMB compared to a loss of 58.834 million RMB in the same period last year.